SDZ-62-434

• UNSPSC Description:

  SDZ-62-434 is a platelet-activating factor (PAF) antagonist. SDZ-62-434 has antiproliferative activity in human solid and haematological malignancies[1].

• Target Antigen:

  Platelet-activating Factor Receptor (PAFR)

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/sdz-62-434.html

• Solubility:

  10 mM in DMSO

• Smiles:

  [H]Cl.[H]Cl.C12=C(C=C(C3=CC=C(CN4CCCCC4)C=C3)N5C2=NCC5)C=CC=C1

• Molecular Weight:

  416.39

• References & Citations:

  [1]V G Brunton, et al. In vitro antitumour activity of the novel imidazoisoquinoline SDZ 62-434. Br J Cancer. 1993 May;67(5):989-95.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  Phase 1

• CAS Number:

  115621-95-9